ERBB2 and breast cancer: We verified that the expression levels of KRT14, CDH1, CDH2, VIM, SNAI1, SNAI2, TWIST1, and ZEB1 did not show a difference between HER2-negative and HER2-positive breast cancer patients (Supplementary Figure S1A).